Cargando…

The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19

Evidence from the global outbreak of SARS-CoV-2 has clearly demonstrated that individuals with pre-existing comorbidities are at a much greater risk of dying from COVID-19. This is of great concern for individuals living with these conditions, and a major challenge for global healthcare systems and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Callender, Lauren A., Curran, Michelle, Bates, Stephanie M., Mairesse, Maelle, Weigandt, Julia, Betts, Catherine J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437504/ https://www.ncbi.nlm.nih.gov/pubmed/32903476 http://dx.doi.org/10.3389/fimmu.2020.01991

Ejemplares similares

Set Up for Failure: Pre-Existing Autoantibodies in Lung Transplant
por: McQuiston, Alexander, et al.
Publicado: (2021)

Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity
por: Izmirly, Abdullah M., et al.
Publicado: (2020)

Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization
por: Wang, Jin, et al.
Publicado: (2021)

Rethinking detection of pre-existing and intervening Plasmodium infections in malaria clinical trials
por: Owalla, Tonny J., et al.
Publicado: (2022)

Ethnicity, pre-existing comorbidities, and outcomes of hospitalised patients with COVID-19
por: Santorelli, Gillian, et al.
Publicado: (2021)

Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-κB
por: Al Zoubi, Sura, et al.
Publicado: (2018)

Isolating Human Monoclonal Antibodies Against Adeno-Associated Virus From Donors With Pre-existing Immunity
por: Giles, April R., et al.
Publicado: (2020)

Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
por: Henze, Larissa, et al.
Publicado: (2023)

PERSONALIZING THE OPTIMAL CARDIAC TROPONIN THRESHOLD FOR COVID-19 PROGNOSTICATION BASED ON PRE-EXISTING COMORBIDITIES
por: Ruge, Max, et al.
Publicado: (2022)

Characterization of pre-existing anti-PEG and anti-AGAL antibodies towards PRX-102 in patients with Fabry disease
por: Lenders, Malte, et al.
Publicado: (2023)

Impact of pre-existing comorbidities on outcomes of patients undergoing surgical aortic valve replacement – rationale and design of the international IMPACT registry
por: Bakhtiary, Farhad, et al.
Publicado: (2021)

The Role of Pre-existing Cross-Reactive Central Memory CD4 T-Cells in Vaccination With Previously Unseen Influenza Strains
por: Nienen, Mikalai, et al.
Publicado: (2019)

Pre-Existing Humoral Immunity Enhances Epicutaneously-Administered Allergen Capture by Skin DC and Their Migration to Local Lymph Nodes
por: Hervé, Pierre-Louis, et al.
Publicado: (2021)

Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine
por: Lima, Noemia S., et al.
Publicado: (2021)

Frequent Infection of Cats With SARS-CoV-2 Irrespective of Pre-Existing Enzootic Coronavirus Immunity, Brazil 2020
por: de Oliveira-Filho, Edmilson F., et al.
Publicado: (2022)

Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood
por: Smith, Corinne J., et al.
Publicado: (2022)

Protein re-surfacing of E. coli L-Asparaginase to evade pre-existing anti-drug antibodies and hypersensitivity responses
por: Bootwala, Ali, et al.
Publicado: (2022)

Prospective assessment of pre-existing and de novo anti-HLA IgE in kidney, liver, lung and heart transplantation
por: Mucha, Jasmin, et al.
Publicado: (2023)

Pre-existing CD4 T cell help boosts antibody responses but has limited impact on germinal center, antigen-specific B cell frequencies after influenza infection
por: Besavilla, Danica F., et al.
Publicado: (2023)

Potential diagnostic markers and therapeutic targets for rheumatoid arthritis with comorbid depression based on bioinformatics analysis
por: Zhou, Tao-tao, et al.
Publicado: (2023)

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
por: Halle, Briana Rose, et al.
Publicado: (2021)

Maternal vaccination: shaping the neonatal response to pertussis
por: Callender, Maiya, et al.
Publicado: (2023)

The Real Importance of Pre-Existing Comorbidities on Long-Term Mortality after Acute Kidney Injury
por: Pereira, Mariana B., et al.
Publicado: (2012)

The role of pre-existing comorbidity on the rate of recovery following injury: A longitudinal cohort study
por: Davie, Gabrielle, et al.
Publicado: (2018)

Risk factors for COVID-19 progression and mortality in hospitalized patients without pre-existing comorbidities
por: Liu, Weifang, et al.
Publicado: (2022)

Pre-existing asthma as a comorbidity does not modify cytokine responses and severity of COVID-19
por: Luo, Jian, et al.
Publicado: (2021)

Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination
por: Amraotkar, Alok R., et al.
Publicado: (2022)

Association of Pre-Existing Comorbidities with Disease Severity Among COVID-19 Patients in Eastern Ethiopia
por: Merga, Bedasa Taye, et al.
Publicado: (2022)

Associations of pre-existing comorbidities and COVID-19 in-hospital mortality: an unCoVer analyses
por: Mertens, E, et al.
Publicado: (2022)

Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities
por: Dian, Yating, et al.
Publicado: (2023)

Therapeutic inhibition of MPO stabilizes pre-existing high risk atherosclerotic plaque
por: Chen, Weiyu, et al.
Publicado: (2022)

Is there a link between pre-existing antibodies acquired due to childhood vaccinations or past infections and COVID-19? A case control study
por: Sumbul, Bilge, et al.
Publicado: (2021)

Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization
por: Hauser, Blake M., et al.
Publicado: (2022)

Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunity
por: Desikan, Rajat, et al.
Publicado: (2022)

Application of Genetic Studies to Flow Cytometry Data and Its Impact on Therapeutic Intervention for Autoimmune Disease
por: Orrù, Valeria, et al.
Publicado: (2021)

High Number and Specific Comorbidities Could Impact the Immune Response in COVID-19 Patients
por: Liu, Dafeng, et al.
Publicado: (2022)

Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status
por: Aissatou, Abba, et al.
Publicado: (2023)

Tertiary Lymphoid Structures in Cancers: Prognostic Value, Regulation, and Manipulation for Therapeutic Intervention
por: Sautès-Fridman, Catherine, et al.
Publicado: (2016)

Alarmins, COVID-19 and comorbidities
por: Di Salvo, Eleonora, et al.
Publicado: (2021)

Immunity: Psoriasis comorbid with atherosclerosis
por: Liu, Chunping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a8s463arddd1i8hhps2t4ai3ht